Latest news with #HELM
Economic Times
5 days ago
- Health
- Economic Times
Abu Dhabi Global Health Week 2025 wrap-up: HELM initiative will drive healthcare partnerships, AI-led drug discovery and life science innovation across the Middle East
The second edition of Abu Dhabi Global Health Week (ADGHW) 2025, held under the theme 'Towards Longevity: Redefining Health and Well-being', marked a significant milestone for the UAE's healthcare ambitions. ADVERTISEMENT Held in April 2025 at the Abu Dhabi National Exhibition Centre (ADNEC) under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, ADGHW 2025 concluded on a note of collaborative spirit, ambition, and hope. Delivering 69 engaging sessions and facilitating the signing of 33 strategic Memoranda of Understanding (MoUs), the event convened 14,290 visitors, 1,295 delegates from global organisations, 140 exhibitors, and 271 visionary speakers from 95 countries. Symbolising the emirate's commitment to becoming a global health innovation leader, the announcement of the Health, Endurance, Longevity, and Medicine (HELM) cluster—a cross-institutional initiative led by the Abu Dhabi Investment Office (ADIO) and the Department of Health—came as a major boost to its cross-border healthcare goals, propelled by artificial intelligence (AI) and data-led innovations. The HELM cluster signals a deliberate and strategic evolution of the UAE's life sciences ecosystem, designed to catalyse long-term economic value through health innovation Abu Dhabi's new frontier in life sciences and AI Designed to accelerate the discovery, development, and commercialisation of next-generation medicines, biotechnologies, and personalised therapies, the initiative will be centred on AI and data-centric care ecosystems. ADVERTISEMENT Alessandro Borgogna, Advisor – Cluster Planning and Development at ADIO, said: "HELM is a critical part of ADIO's long-term economic cluster strategy. By concentrating capabilities in health, research and data science within a single integrated cluster, HELM strengthens the emirate's position in healthcare and life sciences that will define the future prosperity and well-being of citizens and residents. The cluster reflects a clear shift from fragmented investment to targeted, high-impact innovation, anchored in infrastructure, highly-skilled talent and strategic partnerships." Alessandro affirmed how this collaboration exemplifies Abu Dhabi's economic ability where world-class institutions, advanced infrastructure, and progressive policies come together to create a conducive environment for businesses to scale, innovate, and drive lasting impact in life science innovation. ADVERTISEMENT Guided by ADIO's cluster development strategy, HELM is creating the foundation for an 'AI-powered discovery ecosystem,' structured to foster end-to-end innovation across research, regulation and commercial deployment. Precision medicine momentum, multi-partner alliance ADVERTISEMENT Through an AI-driven discovery ecosystem, the HELM cluster's mission is to fuel the development of novel therapeutics. The initiative includes support for creating scalable infrastructure to handle and interpret large volumes of complex healthcare data—spanning clinical, genomic, and proteomic domains—by leveraging the capabilities of Abu Dhabi-based firms specialising in healthcare delivery and data coalition, which includes partners like Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) and Hub71, intends to facilitate targeted interventions to solve some of the most complex and cost-intensive healthcare challenges—oncology, rare diseases, and metabolic disorders. Through the establishment of a comprehensive precision medicine ecosystem, this healthcare coalition aims to bring positive, patient-centred outcomes. ADVERTISEMENT The collaboration will also focus on expediting the generation of intellectual property and facilitating the commercialisation of advanced healthcare innovations within the emirate. Companies engaged in the co-development of AI-enabled discovery technologies will gain access to ADIO's competitive support offerings to establish and grow their operations within the HELM cluster and expand into international Excellency Dr Noura Khamis Al Ghaithi, Undersecretary of DoH, said: 'AI and data are today's enablers of smarter, predictive, preventive, and more personalised care. Through the HELM cluster, we are building a globally connected ecosystem that empowers researchers, innovators, and investors to unlock the full potential of data-driven discovery. From early diagnostics to personalised therapies, Abu Dhabi is positioning itself as a hub where cutting-edge science meets real-world impact.' Nurturing talent and startups through deep tech integration With foundational backing from some of Abu Dhabi's most influential institutions, including DoH, ADIO, ADIA Lab, Abu Dhabi Stem Cells Centre (ADSCC), NYU Abu Dhabi, UAE University, Hub71 and MBZUAI, the HELM cluster is emerging as a critical platform for companies and talent at the intersection of life sciences and deep tech. Each partner contributes distinct strategic value that integrates cutting-edge technologies with real-world healthcare challenges. This lays the foundations for a new generation of homegrown entrepreneurs, researchers and DoH provides a progressive regulatory environment conducive to innovation, while unlocking access to clinical networks and healthcare infrastructure. ADIO accelerates market entry and expansion with tailored investor support through competitive business and facilitation services. ADIA Lab injects deep expertise in AI and computational science and analytics, which are core to unlocking insights from complex health datasets at institutions contribute the scientific aspect. ADSCC and NYU Abu Dhabi provide frontline expertise in regenerative medicine, genomics and personalised therapeutics. UAE University adds academic rigour and a robust talent pipeline to sustain long-term innovation Abu Dhabi's global tech ecosystem, connects startups to funding, expert mentorship and international market access, enabling early-stage companies to commercialise and scale globally. MBZUAI integrates cutting-edge AI capabilities into the cluster by combining research, education and industry collaboration to drive the development of intelligent health fully integrated cluster aims to cultivate talent and accelerate the growth of high-potential ventures. Through coordinated initiatives like training programmes, research fellowships, innovation challenges and infrastructure sharing, HELM is positioning Abu Dhabi as a hub for healthtech innovation and a magnet for global talent. By merging deep tech with life sciences, HELM is establishing a sustainable innovation ecosystem capable of transforming healthcare both locally and noted that through close collaboration with startups and industry stakeholders, the HELM cluster seeks to provide researchers, students, and entrepreneurs with the necessary skills and supportive ecosystem to advance transformative innovations in areas such as precision medicine, genomics, and pharmaceutical development—further strengthening Abu Dhabi's position as a global centre for AI-enabled healthcare innovation. The next era in preventive and personalised care With non-communicable diseases such as cardiovascular illnesses and diabetes rising across the region and globally, HELM is set to accelerate the research, development, manufacturing, and commercialisation of groundbreaking medicines, biotechnologies, and therapies. By integrating AI and advanced healthcare data analytics, the initiative provides support to develop scalable infrastructure for managing and analysing complex healthcare data, including clinical, genomic, and proteomic datasets, fleveraging Abu Dhabi-based companies' expertise in healthcare services and data management. The ecosystem also supports Abu Dhabi's broader ambition of transitioning from a reactive to a preventive health model—one where longevity, quality of life, and individualised treatment are central outcomes. A legacy of collaboration and ambitionADGHW 2025 closed with a clear message: Abu Dhabi is building and reimagining the future of healthcare. From forging precision medicine alliances to enabling AI-powered breakthroughs through HELM, the event showcased how multisector collaboration, government leadership, and innovation ecosystems can converge to redefine the boundaries of healthcare. As the global health landscape evolves, Abu Dhabi's efforts signal a paradigm shift—where the integration of science, technology, and policy becomes the cornerstone for delivering resilient, equitable, and sustainable health systems for generations to come. Disclaimer: This content was authored by the content team of the ET Spotlight team. The news and editorial staff of ET had no role in the creation of this article. (You can now subscribe to our Economic Times WhatsApp channel) (This article is generated and published by ET Spotlight team. You can get in touch with them on etspotlight@
Time of India
5 days ago
- Health
- Time of India
Abu Dhabi Global Health Week 2025 wrap-up: HELM initiative will drive healthcare partnerships, AI-led drug discovery and life science innovation across the Middle East
The second edition of Abu Dhabi Global Health Week (ADGHW) 2025, held under the theme 'Towards Longevity: Redefining Health and Well-being', marked a significant milestone for the UAE's healthcare ambitions. Held in April 2025 at the Abu Dhabi National Exhibition Centre (ADNEC) under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, ADGHW 2025 concluded on a note of collaborative spirit, ambition, and hope. Delivering 69 engaging sessions and facilitating the signing of 33 strategic Memoranda of Understanding (MoUs), the event convened 14,290 visitors, 1,295 delegates from global organisations, 140 exhibitors, and 271 visionary speakers from 95 countries. Symbolising the emirate's commitment to becoming a global health innovation leader, the announcement of the Health, Endurance, Longevity, and Medicine (HELM) cluster—a cross-institutional initiative led by the Abu Dhabi Investment Office (ADIO) and the Department of Health—came as a major boost to its cross-border healthcare goals, propelled by artificial intelligence (AI) and data-led innovations. The HELM cluster signals a deliberate and strategic evolution of the UAE's life sciences ecosystem, designed to catalyse long-term economic value through health innovation Abu Dhabi's new frontier in life sciences and AI Live Events Designed to accelerate the discovery, development, and commercialisation of next-generation medicines, biotechnologies, and personalised therapies, the initiative will be centred on AI and data-centric care ecosystems. Alessandro Borgogna, Advisor – Cluster Planning and Development at ADIO, said: "HELM is a critical part of ADIO's long-term economic cluster strategy. By concentrating capabilities in health, research and data science within a single integrated cluster, HELM strengthens the emirate's position in healthcare and life sciences that will define the future prosperity and well-being of citizens and residents. The cluster reflects a clear shift from fragmented investment to targeted, high-impact innovation, anchored in infrastructure, highly-skilled talent and strategic partnerships." Alessandro affirmed how this collaboration exemplifies Abu Dhabi's economic ability where world-class institutions, advanced infrastructure, and progressive policies come together to create a conducive environment for businesses to scale, innovate, and drive lasting impact in life science innovation. Guided by ADIO's cluster development strategy, HELM is creating the foundation for an 'AI-powered discovery ecosystem,' structured to foster end-to-end innovation across research, regulation and commercial deployment. Precision medicine momentum, multi-partner alliance Through an AI-driven discovery ecosystem, the HELM cluster's mission is to fuel the development of novel therapeutics. The initiative includes support for creating scalable infrastructure to handle and interpret large volumes of complex healthcare data—spanning clinical, genomic, and proteomic domains—by leveraging the capabilities of Abu Dhabi-based firms specialising in healthcare delivery and data solutions. This coalition, which includes partners like Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) and Hub71, intends to facilitate targeted interventions to solve some of the most complex and cost-intensive healthcare challenges—oncology, rare diseases, and metabolic disorders. Through the establishment of a comprehensive precision medicine ecosystem, this healthcare coalition aims to bring positive, patient-centred outcomes. The collaboration will also focus on expediting the generation of intellectual property and facilitating the commercialisation of advanced healthcare innovations within the emirate. Companies engaged in the co-development of AI-enabled discovery technologies will gain access to ADIO's competitive support offerings to establish and grow their operations within the HELM cluster and expand into international markets. Her Excellency Dr Noura Khamis Al Ghaithi, Undersecretary of DoH, said: 'AI and data are today's enablers of smarter, predictive, preventive, and more personalised care. Through the HELM cluster, we are building a globally connected ecosystem that empowers researchers, innovators, and investors to unlock the full potential of data-driven discovery. From early diagnostics to personalised therapies, Abu Dhabi is positioning itself as a hub where cutting-edge science meets real-world impact.' Nurturing talent and startups through deep tech integration With foundational backing from some of Abu Dhabi's most influential institutions, including DoH, ADIO, ADIA Lab, Abu Dhabi Stem Cells Centre (ADSCC), NYU Abu Dhabi, UAE University, Hub71 and MBZUAI, the HELM cluster is emerging as a critical platform for companies and talent at the intersection of life sciences and deep tech. Each partner contributes distinct strategic value that integrates cutting-edge technologies with real-world healthcare challenges. This lays the foundations for a new generation of homegrown entrepreneurs, researchers and technologists. The DoH provides a progressive regulatory environment conducive to innovation, while unlocking access to clinical networks and healthcare infrastructure. ADIO accelerates market entry and expansion with tailored investor support through competitive business and facilitation services. ADIA Lab injects deep expertise in AI and computational science and analytics, which are core to unlocking insights from complex health datasets at scale. Research institutions contribute the scientific aspect. ADSCC and NYU Abu Dhabi provide frontline expertise in regenerative medicine, genomics and personalised therapeutics. UAE University adds academic rigour and a robust talent pipeline to sustain long-term innovation capacity. Hub71, Abu Dhabi's global tech ecosystem, connects startups to funding, expert mentorship and international market access, enabling early-stage companies to commercialise and scale globally. MBZUAI integrates cutting-edge AI capabilities into the cluster by combining research, education and industry collaboration to drive the development of intelligent health technologies. This fully integrated cluster aims to cultivate talent and accelerate the growth of high-potential ventures. Through coordinated initiatives like training programmes, research fellowships, innovation challenges and infrastructure sharing, HELM is positioning Abu Dhabi as a hub for healthtech innovation and a magnet for global talent. By merging deep tech with life sciences, HELM is establishing a sustainable innovation ecosystem capable of transforming healthcare both locally and globally. Haddadin noted that through close collaboration with startups and industry stakeholders, the HELM cluster seeks to provide researchers, students, and entrepreneurs with the necessary skills and supportive ecosystem to advance transformative innovations in areas such as precision medicine, genomics, and pharmaceutical development—further strengthening Abu Dhabi's position as a global centre for AI-enabled healthcare innovation. The next era in preventive and personalised care With non-communicable diseases such as cardiovascular illnesses and diabetes rising across the region and globally, HELM is set to accelerate the research, development, manufacturing, and commercialisation of groundbreaking medicines, biotechnologies, and therapies. By integrating AI and advanced healthcare data analytics, the initiative provides support to develop scalable infrastructure for managing and analysing complex healthcare data, including clinical, genomic, and proteomic datasets, fleveraging Abu Dhabi-based companies' expertise in healthcare services and data management. The ecosystem also supports Abu Dhabi's broader ambition of transitioning from a reactive to a preventive health model—one where longevity, quality of life, and individualised treatment are central outcomes. A legacy of collaboration and ambition ADGHW 2025 closed with a clear message: Abu Dhabi is building and reimagining the future of healthcare. From forging precision medicine alliances to enabling AI-powered breakthroughs through HELM, the event showcased how multisector collaboration, government leadership, and innovation ecosystems can converge to redefine the boundaries of healthcare. As the global health landscape evolves, Abu Dhabi's efforts signal a paradigm shift—where the integration of science, technology, and policy becomes the cornerstone for delivering resilient, equitable, and sustainable health systems for generations to come.
Time of India
5 days ago
- Health
- Time of India
Investing in tomorrow's health: Abu Dhabi's strategic health and life sciences agenda
Abu Dhabi Global Health Week (ADGHW) 2025 showcased the Emirate's bold vision to transform health and life sciences into a powerhouse of innovation, investment, and economic growth. More than a hub for health delivery, Abu Dhabi has positioned itself as a platform for global breakthroughs, where technologists, scientists, investors, and policymakers co-create solutions backed by committed capital, agile regulation, and a unified health ecosystem. Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council and organised by the Department of Health – Abu Dhabi (DoH), this year's edition was anchored around the theme 'Towards Longevity: Redefining Health and Well-being.' The event provided a platform for leaders in policy, technology, finance, and research to explore a new paradigm—one that integrates artificial intelligence (AI), data science, genomics, and patient-centred design to achieve better outcomes. Abu Dhabi's Evolving Model At the core of ADGHW 2025 is Abu Dhabi's focus on longevity, prevention, and precision health, driven by advanced technologies and a connected health ecosystem. The Emirate's commitment to personalised care is supported by world-class research centres, integrated data platforms, investment-friendly policies, and forward-thinking regulations. The launch of the Health, Endurance, Longevity, and Medicine Cluster (HELM) marked a major milestone. Designed to attract international investment and talent, HELM will accelerate Abu Dhabi's transition into a global hub for biotech, MedTech, and life sciences manufacturing. By 2045, the cluster is projected to contribute AED 94 billion (USD 25.6 billion) to GDP and attract AED 42 billion (USD 11.4 billion) in investment. The cluster integrates cutting-edge laboratories, advanced manufacturing facilities, and a supportive regulatory environment to fast-track innovation from lab to market. 'We are building an intelligent health system that embeds AI, genomics, and data-driven insights into every layer of care,' said H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of Department of Health. 'Our vision is globally connected, prevention-first model, delivering personalised impact at scale, supported by strategic investment, bold partnerships, and a unified ecosystem.' Live Events Abu Dhabi is cultivating a thriving life sciences sector, evolving from an import-heavy, treatment-oriented model to a regional hub for R&D, clinical innovation, and biotech scale-up. Investors are taking notice. Complementing HELM, a landmark infrastructure agreement between DoH, the Abu Dhabi Investment Office (ADIO), and Masdar City will establish state-of-the-art life sciences laboratories to enable R&D, support early-stage ventures, and foster academic–industry collaboration. The goal: translate research into commercially viable solutions and grow the life sciences economy from bench to bedside. E mbedding Intelligence in Health The Emirate's vision for health innovation includes significant investment in digital infrastructure and talent. From telehealth to AI-integrated diagnostics and predictive analytics, Abu Dhabi is embedding intelligence across the patient journey—while building a skilled workforce ready to harness emerging technologies. 'Abu Dhabi is not just adopting digital health tools—we're architects of a smart health ecosystem,' said Ibrahim Al Jallaf, Executive Director of Digital Health at Department of Health (DoH). 'By aligning regulation, education, innovation, and investment, we're creating a seamless, data-driven care environment that empowers both clinicians and patients.' Strategic Health Infrastructure Abu Dhabi's life sciences push is supported by initiatives that extend beyond innovation to include robust global logistics. A key announcement at ADGHW 2025 was the inauguration of a regional vaccine distribution hub—a major milestone in the Emirate's strategy to strengthen global health supply chains. Building on a 2024 MoU with GSK, the hub leverages Abu Dhabi's strategic location, advanced logistics infrastructure, and strong regulatory frameworks to ensure rapid, equitable access to vaccines across regional and global markets. This initiative underscores Abu Dhabi's integrated approach to health innovation, where infrastructure, policy, and international collaboration converge to create a future-ready health system that is agile, inclusive, and impact-driven. Life Sciences as an economic engine The life sciences sector is fast becoming a cornerstone of Abu Dhabi's economic diversification strategy. Recent projections indicate the sector will contribute over AED 94 billion to GDP by 2045 and create more than 30,000 jobs. With streamlined regulation, strong intellectual property protections, and support for public–private partnerships, Abu Dhabi offers a compelling environment for investors. Its world-class logistics and distribution networks further enhance its attractiveness as a base for pharmaceutical and MedTech companies looking to scale. Strengthening global ties India and Abu Dhabi share strategic interests in health technology and research translation. Ongoing collaborations in digital diagnostics, genomics, and health data governance create space for joint innovation, particularly relevant as both nations invest in technology-led, accessible healthcare models. Looking ahead Abu Dhabi is not just building a health system; it is building a future-ready life sciences economy. Through bold policy, cross-sector collaboration, and long-term investment, it is creating a platform where global breakthroughs are enabled and scaled responsibly. In a world seeking resilient, innovative health systems, Abu Dhabi offers a powerful and actionable model for the future of global health innovation.
TECHx
21-06-2025
- Health
- TECHx
Abu Dhabi, Abbott Partner to Boost Local Pharma Sector
Home » Smart Sectors » Healthcare » Abu Dhabi, Abbott Partner to Boost Local Pharma Sector The Department of Health, Abu Dhabi (DoH), the healthcare sector regulator in Abu Dhabi, announced a strategic partnership with global healthcare leader Abbott. The agreement was signed during the BIO International Convention held in Boston, USA. The partnership aims to localise pharmaceutical manufacturing in Abu Dhabi. It also focuses on advancing digital health solutions across the emirate. Officials revealed that the collaboration builds on Abu Dhabi's advanced life sciences infrastructure. This move supports the emirate's goal to reduce dependency on imports and strengthen supply chain resilience. It further reflects Abu Dhabi's commitment to fostering a self-sufficient and sustainable healthcare ecosystem. Dr. Noura Al Ghaithi, Undersecretary of DoH, stated that the partnership follows the recent launch of the Health, Endurance, Longevity and Medicine (HELM) Cluster in Abu Dhabi. She added that the emirate is equipped with an integrated infrastructure to support local manufacturing and R&D. She said the agreement would position Abu Dhabi as a regional healthcare hub and leader in life sciences. According to her, aligning DoH's strategic vision with Abbott's global expertise will accelerate the delivery of innovative healthcare products and solutions. The collaboration is built around four key pillars: Localising Abbott's pharmaceutical portfolio and developing biosimilars. Advancing digital transformation through electronic patient information leaflets. Launching education programs to strengthen the healthcare workforce. Supporting regulatory alignment and joint R&D initiatives. Mazen Bachir, Regional Director for Abbott's established pharmaceuticals business in the Gulf, Emerging Markets and Levant, reported that this partnership will enhance healthcare resilience and innovation in Abu Dhabi. He highlighted Abbott's ongoing commitment to the UAE's healthcare system. He noted that the partnership will also include digitising life sciences product information and launching training initiatives to build local capabilities. In addition, both parties will explore opportunities for joint research and development. DoH also reported that a high-level delegation has embarked on a strategic mission to the United States from 15 to 21 June 2025. The delegation will conduct over 20 meetings with public and private sector leaders. These meetings aim to promote knowledge exchange, attract investments, and sign new agreements that accelerate advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes: Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, and PureHealth. Etihad Cargo, New York University Abu Dhabi, Khalifa University, startAD, and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI). This announcement highlights Abu Dhabi's global ambitions in life sciences and healthcare innovation.
Zawya
15-06-2025
- Health
- Zawya
Abu Dhabi reinforces global leadership in healthcare innovation with high-level U.S. visit
Abu Dhabi, United Arab Emirates – A high-level delegation led by the Department of Health – Abu Dhabi (DoH), is set to embark on a strategic mission to the United States from June 14 to 21, 2025. The visit reaffirms Abu Dhabi's global leadership in healthcare innovation and reflects its broader vision for healthcare transformation—driven by innovation, investment, and a deep commitment to global collaboration. The delegation will visit key U.S. cities including Boston, Washington D.C., and Philadelphia, in parallel with Abu Dhabi's participation at BIO International Convention 2025, one of the world's foremost biotechnology events. The visit will spotlight the Emirate's achievements in AI, digital health, genomics, and clinical research and showcase Abu Dhabi's Health, Endurance, Longevity and Medicine (HELM) Life Science Cluster, while promoting long-term strategic partnerships with government entities, research institutions, and global innovators. H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated: 'This mission reflects our commitment to shaping the future of health through collaboration, innovation, and shared purpose. Our vision is to build a health system that predicts, prevents, acts to restore, and acts to cure, therefore ensuring better outcomes for our communities and beyond. This can only be achieved through meaningful partnerships and a shared ambition to improve lives. We are proud to join our partners in the United States to explore new opportunities that advance healthcare, both in the UAE and globally.' The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities, and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo. Abu Dhabi continues to lead the region in genomics through the Emirati Genome Programme, which has successfully sequenced over 800,000 samples, creating one of the most advanced national genomic databases. The Emirate is also home to more than 90 licensed research centers and 30+ ongoing clinical trials in areas such as oncology, rare diseases, and chronic conditions. Advanced data platforms such as Malaffi, which securely store over 5 million patient records—enable AI-powered insights and real-world evidence, while national initiatives like the Golden Visa program are cultivating a global workforce and have granted over 2,000 long-term visas for researchers and healthcare professionals from around the world. About the Department of Health – Abu Dhabi (DoH): The Department of Health – Abu Dhabi is the regulative body of the healthcare sector in the Emirate of Abu Dhabi. Committed to ensuring excellence in healthcare, DoH monitors the health status of the population while shaping the regulatory framework for the health system. This includes inspecting against regulations, enforcing standards and encouraging the adoption of world-class best practices and performance targets by all healthcare providers in the Emirate. Abu Dhabi remains dedicated to shaping the future of healthcare by establishing an intelligent and sustainable ecosystem that prioritises health, longevity and quality of life for all community members. Leveraging state-of-the-art infrastructure and cutting-edge capabilities, DoH continues to develop and implement initiatives and programmes in line with its strategic focus areas, Healthy Population, Best-in-Class Care and Resilience and Innovation. These efforts reflect DoH's unwavering commitment to predicting, preventing and personalising healthcare for every individual. For further information on DOH, visit and follow on X, Instagram, Facebook, LinkedIn and YouTube. For media inquiries, please contact: Mariam Al Marzooqi, msalmarzooqi@
